PROPOFOL 2% MCT Fresenius 1 g/50ml ser pré
7680628740026
CH-62874
N01AX10
01.02.1.
1 / 3
google
Details
- Product number
- 6287402
- CPT
- -
- Packaging group
- 1 x 50 ml
- Unit
- Fertigspritze(n)
- Composition
- propofolum 20 mg, sojae oleum 50 mg, triglycerida media, glycerolum, phospholipida ex ovo purificata, acidum oleicum, natrii hydroxidum, aqua ad iniectabile q.s. ad emulsionem pro 1 ml corresp. natrium 0.06 mg.
Articles (1)
Propofol MCT Fresenius 20 mg/ml Fertigspritze, Emulsion zur Infusion in einer Fertigspritze
Fertigspritze
1 x 50 ml
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
propofolum
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
sojae oleum
|
50.0 MG | Substance | HBESI |
|
triglycerida media
|
- | Substance | HNIDK |
|
glycerolum
|
- | Substance | HNIDK |
|
phospholipida ex ovo purificata
|
- | Substance | HNIDK |
|
acidum oleicum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
0.06 MG | Substance | HBESI |
Authorization holder
Fresenius Kabi (Schweiz) AG
6010 Kriens
Authorization information
- Swissmedic authorization number
- 62874
- Drug name
- Propofol MCT Fresenius Fertigspritze, Emulsion zur Injektion/Infusion in einer Fertigspritze
- Galenic form
- EMIF
- ATC Code
- N01AX10
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 23/09/2013
- Authorization expiration date
- 31/12/9999
- IT number
- 01.02.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PROPOFOL 2% MCT Fresenius 1 g/50ml ser pré
- Description (DE)
- PROPOFOL 2% MCT Fresenius 1 g/50ml Fertspr
- Market launch
- 23/09/2013
- Narcotic (BTM)
- No